Services
Development Services
Formulation
Solubility & Bioavailability Enhancement
Micro and Nanotechnology
Drug / Device Combination Products
Biopharmaceutical
Proprietary Technology
Feasibility Programs
Manufacturing Services
Aseptic Manufacturing
Pre-clinical Manufacturing
Clinical Manufacturing
Commercial Manufacturing
ICH Stability Programs
Analytical Services
Analytical Method Development and Validation
Drug Release Testing
Physical Characterization
Stability Indicating Method Development
Dosage Forms
Solutions and Suspensions
Implantable Drug Delivery Systems and Combination Products
Microparticle and Gel Depot Injections
Oral Solid Dose
Semi-Solids and Gels
Powders
Markets Served
Ophthalmic
Long-Acting Drug Delivery
Oral Drug Delivery
Topical, Mucosal, and Transdermal
Injectables / Parenteral
Resource Center
Our Blog
Press Releases
Case Studies
Webinars / Presentations
Published Articles
Technical Briefs
Scientific Publications
Events
About Us
Management Team
Employment
Contact Us
Services
Development Services
Formulation
Solubility & Bioavailability Enhancement
Micro and Nanotechnology
Drug / Device Combination Products
Biopharmaceutical
Proprietary Technology
Feasibility Programs
Manufacturing Services
Aseptic Manufacturing
Pre-clinical Manufacturing
Clinical Manufacturing
Commercial Manufacturing
ICH Stability Programs
Analytical Services
Analytical Method Development and Validation
Drug Release Testing
Physical Characterization
Stability Indicating Method Development
Dosage Forms
Solutions and Suspensions
Implantable Drug Delivery Systems and Combination Products
Microparticle and Gel Depot Injections
Oral Solid Dose
Semi-Solids and Gels
Powders
Markets Served
Ophthalmic
Long-Acting Drug Delivery
Oral Drug Delivery
Topical, Mucosal, and Transdermal
Injectables / Parenteral
Resource Center
Our Blog
Press Releases
Case Studies
Webinars / Presentations
Published Articles
Technical Briefs
Scientific Publications
Events
About Us
Management Team
Employment
Contact Us
Case Studies
Case Study – Solving Solubility Challenges for a Novel Oncology Drug
